Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nomisma Healthcare is an India-based manufacturer of bioresorbable polymers used in pharmaceutical formulations, medical devices, cosmetic applications, and tissue engineering. The company specializes in high-purity PLGA, PLA, PCL, and custom copolymers, including lyophilized, tin-free, and sterilized polymer grades for controlled-release injectables and implantable applications. Rather than developing its own therapeutic drug pipeline, Nomisma operates as an enabling materials and technology supplier to pharma and medical device companies, supporting research through commercial production. Its capabilities include custom polymer synthesis, analytical characterization, and quality-focused manufacturing for global customers. The business appears to be positioned as a specialty healthcare materials company serving drug delivery and biomedical product developers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nomisma.